# A Study to Investigate a New Treatment in Patients With Parkinson's Disease

> **NCT03407378** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tools4Patient** · enrollment: 110 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** IPT803
- **GENETIC:** Optional pharmacogenetic assessment
- **OTHER:** Questionnaires
- **OTHER:** Optional Blood-Oxygen-level Dependent functionalMRI
- **OTHER:** Motor Assessments before taking regular PD treatment
- **OTHER:** Motor Assessments on regular PD treatment

## Key facts

- **NCT ID:** NCT03407378
- **Lead sponsor:** Tools4Patient
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-26
- **Primary completion:** 2020-02-07
- **Final completion:** 2020-03-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03407378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03407378, "A Study to Investigate a New Treatment in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03407378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*